June 22, 2022

Anixa Publishes Scientific Paper On Preventative Ovarian Cancer Technology

(RTTNews) – Anixa Biosciences, Inc. (ANIX) announced the publication of a peer-reviewed journal article in Clinical and Experimental Vaccine Research, which is titled, Formulation of an ovarian cancer vaccine with the squalene-based AddaVax adjuvant inhibits the growth of murine

This post was originally published on this site

Sign Up To Get FREE News, Tips and Offers!

X